ALX Oncology Presents Initial Data from the ALX148 Clinical Trial Non-Hodgkin Lymphoma Combination Cohort at the 61st American Society of Hematology (ASH)
DUBLIN, Ireland & BURLINGAME, Calif.--(BUSINESS WIRE)--Dec 7, 2019--
DUBLIN, Ireland & BURLINGAME, Calif.--(BUSINESS WIRE)--Dec 7, 2019--